CSNV.Y Stock Overview
Provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Corbion N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €26.35 |
| 52 Week High | €28.56 |
| 52 Week Low | €17.91 |
| Beta | 0.98 |
| 11 Month Change | -2.73% |
| 3 Month Change | 9.86% |
| 1 Year Change | n/a |
| 33 Year Change | -45.25% |
| 5 Year Change | -17.58% |
| Change since IPO | -21.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| CSNV.Y | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | 3.9% |
| 1Y | n/a | 11.5% | 33.2% |
Return vs Industry: Insufficient data to determine how CSNV.Y performed against the US Chemicals industry.
Return vs Market: Insufficient data to determine how CSNV.Y performed against the US Market.
Price Volatility
| CSNV.Y volatility | |
|---|---|
| CSNV.Y Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.4% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CSNV.Y's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CSNV.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 2,727 | Olivier Rigaud | www.corbion.com |
Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors.
Corbion N.V. Fundamentals Summary
| CSNV.Y fundamental statistics | |
|---|---|
| Market cap | US$1.38b |
| Earnings (TTM) | US$85.02m |
| Revenue (TTM) | US$1.53b |
16.3x
P/E Ratio0.9x
P/S RatioIs CSNV.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CSNV.Y income statement (TTM) | |
|---|---|
| Revenue | €1.44b |
| Cost of Revenue | €1.10b |
| Gross Profit | €341.30m |
| Other Expenses | €261.20m |
| Earnings | €80.10m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 27, 2025
| Earnings per share (EPS) | 1.38 |
| Gross Margin | 23.71% |
| Net Profit Margin | 5.57% |
| Debt/Equity Ratio | 58.5% |
How did CSNV.Y perform over the long term?
See historical performance and comparison